Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- J. Stuart Elborn, MD
National Heart and Lung Institute, Imperial College
Principal Investigator - James Chmiel, MD
Indiana University School of Medicine/Riley Physicians Pulmonary
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
105 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cystic Fibrosis Centre Innsbruck Medical University of Innsbruck, Dept. for Child and Adolescent Health, University Clinic for Paediatrics, Cardiology, Pneumology, Allergology, Cystic Fibrosis
Innsbruck, Austria
- Medical University of Vienna
Vienna, Austria
- Universitair Ziekenhuis Brussel
Brussels, Belgium
- Medical Center Prolet Eood
Rousse, Bulgaria
- Umhat Alexandrovska
Sofia, Bulgaria
- Mhat Sveta Marina Ead
Varna, Bulgaria
- Centre Hospitalier de L'Université de Montréal (chum)
Montreal, Canada
- St. Michael'S Hospital
Toronto, Canada
- the Hospital for Sick Children
Toronto, Canada
- St. Paul'S Hospital
Vancouver, Canada
- Motol University Hospital
Prague, Czechia
- Centre de Référence de la Mucoviscidose
Bron, France
- Service de Pneumologie, Allergologie, Mucoviscidose; Hôpital Femme-Mère-Enfant
Bron, France
- Service de Pediatrie Medico-Chirurgicale Et Genetique
Dijon, France
- Chru de Montpellier
Montpellier, France
- Crcm Enfant de Nancy
Nancy, France
- Chu de Nice
Nice, France
- Crcm Hôpital Necker
Paris, France
- Centre de Recherche En Explorations Fonctionnelles (cref)
Paris, France
- Foundation Ildys
Roscoff, France
- Nouvel Hopital Civil Strasbourg
Strasbourg, France
- Charité Universitätsmedzin
Berlin, Germany
- Catholic Hospital Bochum - St. Josef-Hospital
Bochum, Germany
- University Hospital Essen
Essen, Germany
- University Medicine Essen Ruhrlandklinik
Essen, Germany
- Goethe University Children´s Hospital
Frankfurt, Germany
- Hannover Medical School
Hanover, Germany
- University Hospital Jena
Jena, Germany
- Klinikum Der Ludwig Maximilian Universität München
München, Germany
- General Hospital of Thessaloniki Ippokratio
Thessaloniki, Greece
- National Koranyi Institute of Pulmonology, Department of Cystic Fibrosis
Budapest, Hungary
- University of Debrecen - Kenezy Gyula University Hospital
Debrecen, Hungary
- Bács-Kiskun County Hospital, Teaching Hospital of the University of Szeged
Kecskemét, Hungary
- Moritz Kaposi General Hospital, Mosdós, Department of Pediatric Pulmonary Rehabilitation
Mosdós, Hungary
- Pediatric Pulmonology, Törökbálint, Hungary
Törökbálint, Hungary
- Centro Regionale Toscano Di Riferimento Per la Fibrosi Cistica
Florence, Italy
- U.O.S.D. - Centro Fibrosi Cistica
Genova, Italy
- Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
- Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Milan, Italy
- Azienda Ospedaliera Universitaria Verona
Verona, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2017
- Primary completion
- 17 Jun 2020
- Completion
- 17 Jun 2020
- Last update posted
- 18 Jan 2023
- Registered enrollment
- 447
- Registry id
- NCT03451045
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.